Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IV (Metastatic) Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT04305834
What this trial is testing

Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Hormone Receptor Positive Breast CarcinomaMetastatic Breast Carcinoma+1 more
City of Hope Medical Center 43
Testing effectiveness (Phase 2)Ended earlyNCT00096109
What this trial is testing

Tanespimycin in Treating Women With Refractory Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Recurrent Breast CancerStage IIIB Breast CancerStage IIIC Breast Cancer+1 more
National Cancer Institute (NCI) 11
Not applicableLooking for participantsNCT03723928
What this trial is testing

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Estrogen Receptor PositiveHER2/Neu Negative+3 more
SWOG Cancer Research Network 739
Testing effectiveness (Phase 2)Study completedNCT00068588
What this trial is testing

GTI-2040 and Capecitabine in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Male Breast CancerRecurrent Breast CancerStage IV Breast Cancer
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT00004888
What this trial is testing

Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast Cancer

Who this might be right for
Recurrent Breast CancerStage IV Breast Cancer
National Cancer Institute (NCI) 84
Testing effectiveness (Phase 2)Study completedNCT02536794
What this trial is testing

MEDI4736 and Tremelimumab in Treating Patients With Metastatic HER2 Negative Breast Cancer

Who this might be right for
Estrogen Receptor NegativeEstrogen Receptor PositiveHER2/Neu Negative+2 more
Northwestern University 30
Large-scale testing (Phase 3)UnknownNCT00688194
What this trial is testing

Fulvestrant With or Without Lapatinib and/or Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer That Progressed After Previous Aromatase Inhibitor Therapy

Who this might be right for
Breast Cancer
Gruppo Italiano Mammella (GIM) 396
Testing effectiveness (Phase 2)Ended earlyNCT02183805
What this trial is testing

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Metastatic Triple-negative Breast Cancer

Who this might be right for
Carcinoma Breast Stage IV
Sun Yat-sen University 6
Testing effectiveness (Phase 2)UnknownNCT00002628
What this trial is testing

Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
St. Louis University 50
Testing effectiveness (Phase 2)Study completedNCT00321633
What this trial is testing

Carboplatin or Docetaxel in Treating Women With Metastatic Genetic Breast Cancer

Who this might be right for
brca1 Mutation Carrierbrca2 Mutation CarrierBreast Cancer+1 more
University College London Hospitals 148
Not applicableStudy completedNCT00445952
What this trial is testing

Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant

Who this might be right for
Cancer
European Organisation for Research and Treatment of Cancer - EORTC 304
Early research (Phase 1)UnknownNCT00009763
What this trial is testing

Monoclonal Antibody Therapy, Cyclosporine, and Paclitaxel in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer

Who this might be right for
Breast Cancer
University of California, Davis
Testing effectiveness (Phase 2)Study completedNCT00001193
What this trial is testing

A Multimodality Treatment Approach to Patients With Inflammatory Cancer of the Breast and Locally Advanced Non-Inflammatory Stage III Breast Cancer and Stage IV Breast Cancer

Who this might be right for
Breast NeoplasmsNeoplasm Metastasis
National Cancer Institute (NCI) 200
Testing effectiveness (Phase 2)Study completedNCT00669565
What this trial is testing

Safety and Efficacy Study of Bavituximab Plus Paclitaxel and Carboplatin to Treat Breast Cancer

Who this might be right for
Carcinoma Breast Stage IV
Peregrine Pharmaceuticals 46
Testing effectiveness (Phase 2)Study completedNCT00074100
What this trial is testing

Amonafide in Treating Women With Metastatic Breast Cancer That Has Progressed After Previous Chemotherapy

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00002998
What this trial is testing

Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Alliance for Clinical Trials in Oncology 59
Testing effectiveness (Phase 2)Study completedNCT00051051
What this trial is testing

A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancer

Who this might be right for
Breast Neoplasms
Pfizer 168
Testing effectiveness (Phase 2)Study completedNCT00110045
What this trial is testing

Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant

Who this might be right for
Cancer
European Organisation for Research and Treatment of Cancer - EORTC 171
Testing effectiveness (Phase 2)Active Not RecruitingNCT01463072
What this trial is testing

Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Locally Advanced Breast CarcinomaMetastatic Breast CarcinomaRecurrent Breast Carcinoma+5 more
City of Hope Medical Center 40
Testing effectiveness (Phase 2)Study completedNCT00232505
What this trial is testing

Cetuximab + / - Carboplatin for Estrogen Receptor-Negative, Progesterone Receptor-Negative Metastatic Breast Cancer

Who this might be right for
Breast Cancer
UNC Lineberger Comprehensive Cancer Center 112
Next Page